Pre-clinical evaluation of APrevent® VOIS for unilateral vocal fold paralysis medialization.

OBJECTIVE

To evaluate the concept and efficacy of an adjustable implant (Prototype SH30: porcine implant and APrevent® VOIS: human concept) for treatment of unilateral vocal fold paralysis (UVFP) via in vivo mini-pig studies, human computed tomographic (CT) and magnetic resonance (MR) image analysis, ex-vivo aerodynamic and acoustic analysis.

METHODS

Feasibility testing and prototype implantation were performed using in-vivo UVFP porcine model ( = 8), followed by a dimensional finding study using CT and MR scans of larynges ( = 75) for modification of the implant prototypes. Acoustic and aerodynamic measurements were recorded on excised canine ( = 7) larynges with simulated UVFP before and after medialization with VOIS-Implant.

RESULTS

The prototype showed in the in-vivo UVFP porcine model an improved glottic closure from grade 6 incomplete closure to complete closure ( = 5), to grade 2 incomplete closure ( = 2) and grade 3 incomplete closure ( = 1). On human CT/MR scans the identification of the correct size was successful in 97.3% using the thyroid cartilage alar "distance S" as the only parameter, which is an important step towards procedure standardization and implant design. Results were confirmed with implantation in human laryngeal cadavers ( = 44). Measurements of the acoustic and aerodynamic effects after implantation showed a significant decreased phonation threshold pressure ( = .0187), phonation threshold flow ( = .0001) and phonation threshold power ( = .0046) on excised canine larynges with simulated UVFP. Percent jitter and percent shimmer decreased ( = .2976;  = .1771) but not significant.

CONCLUSIONS

Based on the preclinical results four sizes, differing in medial length, implant width and expansion direction of silicone cushions, seem to be enough to satisfy laryngeal size variations. This concept is significantly effective in medializing UVFP and improving the aerodynamic and acoustic qualities of phonation as reported in a preliminary clinical outcome study with long-term implantation.

LEVEL OF EVIDENCE

N/A.